About
Kate Antrobus is a global health professional and financier with over 15 years of experience expanding access to medical technologies in emerging markets. She has held senior roles at Univercells, where she worked on biomanufacturing for vaccines and biologics, and at Lion's Head Global Partners advising on blended-finance strategies for health systems in low- and middle-income countries; she was also part of the investment team at the Global Health Investment Fund and started her finance career at J.P. Morgan. At Adjuvant she supports portfolio strategy, partnerships, and industrialization models to expand access to health products, focused on deploying capital in sub-Saharan Africa.
Invests in
BiotechDigital HealthImpact & Social Good
Experience
- BluesquareBoard Membercurrent2026 — present
- Adjuvant CapitalOperating Partnercurrent2025 — present
- Campaigns in Global HealthChair of the Board of Trusteescurrent2023 — presentCambridge, England, United Kingdom
- Medicines Development for Global HealthMember of the Board of Directors, Chair UK Entitycurrent2020 — present
- UNIVERCELLSChief Business Officer2023 — 2025Brussels, Brussels Region, Belgium
- UNIVERCELLSChief Investment Officer2021 — 2025Brussels, Brussels Region, Belgium
- UNIVERCELLSGlobal Health & Finance Lead2019 — 2021Brussels Area, Belgium
- Quantoom BiosciencesMember of the Board of Directors2021 — 2025
- EXOTHERAMember of the Board of Directors2021 — 2025
- UNIZIMAMember of the Board of Directors2021 — 2025
- Lion's Head Global PartnersExecutive Director2014 — 2018
- Stop TB PartnershipBoard Member (Private Sector Constituency)2017 — 2018
- J.P. Morgan Asset ManagementPortfolio Analyst2012 — 2014
Education
- University of OxfordBachelor of Arts - BA, Political Science and Government2006 — 2009
- Columbia University2011 — 2012
- The London School of Economics and Political Science (LSE)2010 — 2011
- The London School of Economics and Political Science (LSE)
- The London School of Economics and Political Science (LSE)2010 — 2012
Skills & more
Communication1Marketing1Strategic Thinking1Marketing StrategyBusiness DevelopmentCorporate DevelopmentBoard of Directors
- Chartered Financial Analyst (CFA) — CFA Institute
From Kate's professional profile.
Same school
Also attended University of Oxford687
Reid HoffmanCo-founder of LinkedIn; Partner at GreylockMichael MoritzFormer Partner at Sequoia Capital; Senior Adviser at Sequoia HeritageBrad GerstnerFounder & CEO of Altimeter CapitalDominic JacquessonInvestor at Index VenturesErin Price-WrightInvestor at Index VenturesJan HammerInvestor at Index Ventures
+ 681 more
Also attended Columbia University498
Ben HorowitzCo-founder & General Partner at Andreessen HorowitzDoug LeonePartner at Sequoia Capital; former Global Managing PartnerChris DixonFounder & Managing Partner of a16z crypto at Andreessen HorowitzGabriella GiglioHR & Executive Talent at General CatalystScott BillerInvestor at GV (Google Ventures)Erica VanInvestment Director at Intel Capital
+ 492 more
Also attended The London School of Economics and Political Science (LSE)797
Lee FixelFounder of AdditionPat GradyPartner at Sequoia CapitalCyriac ParisotInvestor at Index VenturesSofia DolfeInvestor at Index VenturesJonas VetterleInvestor at Moonfire VenturesLavinia FerriAssociate at P101 Ventures
+ 791 more
Shared employers
Also worked at UNIVERCELLS1
Also worked at Lion's Head Global Partners2
Also worked at J.P. Morgan Asset Management19
Ralph DeBernardoPartner, Investor Relations at Sapphire VenturesMaxim OwenPartner at Wavemaker Three-Sixty HealthAndrea ChangPartner at NGC VenturesAdrian StewartOperating Partner at Stack AssetLuciana GerminarioPartner, Chief Operating Officer, Member of Executive Committee at Helios Digital VenturesJonathan SilberInvestor at Maccabee Ventures
+ 13 more
Colleagues at Adjuvant Capital
Abrar Haque
Associate at Adjuvant Capital
Alexandra (Sandra) Glucksmann
Advisory Partner at Adjuvant Capital
Christian Mandl
Senior Advisor at Adjuvant Capital
Curt LaBelle
Venture Partner at Adjuvant Capital
David Washer
Investor at Adjuvant Capital
Evelyn Yanatos
Director of Finance and Compliance at Adjuvant Capital
Gerard Cunningham
Operating Partner at Adjuvant Capital
Giulia Balconi
Associate at Adjuvant Capital